UBS Group »

Aligos Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aligos Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 290200k400k600k05k10k15k
Value ($)Share countHistorical ALGS position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $618k 16k 39.84
2024-09-30 $121 14 8.64

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Aligos Therapeutics

Adage Capital Partners GP
EcoR1 Capital
Deep Track Capital
Vivo Capital
Vanguard Group
Baker Bros. Advisors
Hillhouse Capital Advisors
Trexquant Investment
Ikarian Capital
UBS O'Connor
H D Vest Advisory Services
Geode Capital Management
Silverarc Capital Management
Royal Bank of Canada
Drive Wealth Management

View all funds holding Aligos Therapeutics